Administration of the novel antiangiogenic PTC299 in combination with aromatase inhibitors is feasible and shows antitumor activity in metastatic breast cancer Meeting Abstract
| Authors: | Tiersten, A.; Schneider, B. P.; Dickler, M.; Volm, M.; Speyer, J.; Novik, Y.; Lehman, R.; Callahan, L. A.; Darby, C. H.; Miller, L. L.; Miao, H. |
| Abstract Title: | Administration of the novel antiangiogenic PTC299 in combination with aromatase inhibitors is feasible and shows antitumor activity in metastatic breast cancer |
| Meeting Title: | 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 70 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2010 Dec 9-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2010-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209695801151 |
| DOI: | 10.1158/0008-5472.sabcs10-p2-16-08 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-16-08 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
